303 results on '"Abella, Eugenia"'
Search Results
2. Chronic lymphocytic leukemia–like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia
3. Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
4. Bone tissue quality in patients with monoclonal gammopathy of uncertain significance
5. Optimised extraction methods for the determination of trichothecenes in rat faeces followed by liquid chromatography-tandem mass spectrometry
6. Monitoring and evaluation of the interaction between deoxynivalenol and gut microbiota in Wistar rats by mass spectrometry-based metabolomics and next-generation sequencing
7. Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma
8. Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes
9. Determination of mycotoxins in plant-based beverages using QuEChERS and liquid chromatography–tandem mass spectrometry
10. Do Patients and Physicians Agree When They Assess Quality of Life?
11. Immunoparesis Recovery in Transplant-Ineligible Newly Diagnosis Multiple Myeloma Patients: An Independent Prognosis Factor That Could Complement Prognostic Value of Minimal Residual Disease
12. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid
13. Genetic and phenotypic characterisation of HIV ‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
14. P-203: Early mortality and treatment discontinuation in multiple myeloma patients treated in front-line with bortezomib, lenalidomide and dexamethasone (VRD)
15. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
16. NT-proBNP: A cardiac biomarker to assess prognosis in non-Hodgkin lymphoma
17. Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma
18. Cross-sectional study to assess the efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies
19. Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
20. HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era
21. Significado pronóstico de los subtipos inmunológicos de la leucemia aguda linfoblástica T del adulto. Estudio de 81 pacientes
22. Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation
23. Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP
24. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results
25. Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study
26. Reduced Expression of the CD94/NKG2C NK Cell Receptor in Chronic Lymphocytic Leukemia (CLL) and CLL-like Monoclonal B-Cell Lymphocytosis (MBL)
27. Gene Expression and Cytokine Analyses Identify Markers of Progression from CLL-like Monoclonal B-Cell Lymphocytosis to Chronic Lymphocytic Leukemia
28. Deciphering the CXCL9-CXCL10-CXCL11/CXCR3 Axis in CLL-like Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A New Target for Immune Activation?
29. Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients
30. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial
31. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia
32. Rapid infusion of rituximab with or without steroid-containing chemotherapy: 1-yr experience in a single institution
33. Nodal marginal zone lymphoma in AIDS patients: a casual association?
34. Prognostic impact of highly active antiretroviral therapy in HIV-related Hodgkin's disease
35. Isochromosome +i(3)(q10) in a new case of persistent polyclonal B-cell lymphocytosis (PPBL)
36. New factors involved in the appearance of Mandibular Osteonecrosis by Bisphosphonates in Multiple Myeloma. A multicentric study.
37. Prescription Patterns and Outcomes of First-Line Therapy for Non-Transplant Eligible Multiple Myeloma Real-Life Patients According to Age: A Retrospective Analysis of the 2012-2016 Period
38. Successfully non-surgical management of flail chest as first manifestation of multiple myeloma: A case report
39. Anthracycline‐induced cardiotoxicity in diffuse large B‐cell lymphoma: NT‐proBNP and cardiovascular score for risk stratification
40. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance
41. First description of a frameshift mutation in the alpha sub 1-globin gene associated with alpha-thalassaemia
42. Dicentric (17;18) in a Case of Atypical B-Cell Chronic Lymphocytic Leukemia
43. Cytogenetic and Fluorescence In Situ Hybridization Studies in Four Cases of Plasma Cell Leukemia
44. Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study.
45. Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma
46. Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL
47. Long-term Reversibility Analysis of Peripheral Neuropathy in Multiple Myeloma Patients Treated with Bortezomib
48. Incorporation of a Nurse Case Manager for the Diagnosis and Follow Up of Patients with Multiple Myeloma
49. Comparative Study of 18F-FDG-PET-CT and Magnetic Resonance in the Diagnosis of Smoldering Myeloma and Bone Plasmocytoma
50. Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.